Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AXSM
#3445
Axsome Therapeutics, Inc. - Common Stock
2.3
4
USD
+0.71%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.71%
Monthly Change
-98.73%
6 month change
-98.44%
Year Change
-98.20%
Previous Close
2.3
3
Open
2.3
5
Low
2.3
4
High
2.3
5
Volume
133
Markets
US Stock Market
Healthcare
AXSM
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
37.41 M
38.48 M
43.52 M
47.37 M
48.77 M
51.15 M
51.46 M
Valuation ratios
Enterprise value
2.91 B
1.42 B
3.08 B
3.44 B
3.99 B
9.14 B
11.96 B
Price to earnings ratio
—
—
-15.94
-14.62
-14.13
-49.63
-63.05
Price to sales ratio
—
—
—
12.94
10.51
14.23
16.6
Price to cash flow ratio
—
—
-25.58
-24.13
-31.57
-97.27
-165.86
Price to book ratio
—
—
27.21
18.33
71.1
102.9
40.49
Enterprise value to EBITDA ratio
-29.38
—
-13.81
-15.56
-14.87
-58.62
-75.6
Profitability ratios
Return on assets %
-0.55
-1.49
-0.56
-0.41
-0.51
-0.27
-0.09
Return on equity %
-0.9
-8.34
-1.71
-1.25
-5.04
-2.07
-1.18
Return on invested capital %
-4 013.51
-6 425.58
-1 305.05
-883.08
-958.26
-303.87
-114.12
Gross margin %
100
—
—
90.37
91.37
92.56
92.3
Operating margin %
7 950.31
—
—
-85.67
-72.74
-26.12
-33.14
EBITDA margin %
7 947.64
—
—
-81.75
-69.61
-24.41
-31.81
Net margin %
8 251.77
—
—
-88.41
-74.47
-28.69
-33.76
Liquidity ratios
Quick ratio
—
—
2.5
3.52
2.04
1.48
1.32
Current ratio
7.85
3.75
2.54
3.63
2.11
1.55
1.39
Inventory turnover
—
—
1.2
2.68
2.16
1.7
0.5
Asset turnover
-0.01
—
0
0.59
0.67
0.93
0.27
Solvency ratios
Debt to assets ratio
0.26
0.56
0.28
0.3
0.32
0.17
0.27
Debt to equity ratio
0.42
3.14
0.86
0.93
3.17
1.33
3.5
Long term debt to total assets ratio
0.26
0.55
0.28
0.3
0.31
0.17
0.17
Long term debt to total equity ratio
0.42
3.1
0.85
0.92
3.1
1.33
2.16
Per share metrics
Operating cash flow per share
—
—
-2.87
-3.19
-2.68
-1.88
-1.41
EBIT per share
—
—
-5.65
-5.1
-5.86
-3.35
-3.44
EBITDA per share
—
—
-5.49
-4.87
-5.6
-3.13
-3.14
Total debt per share
—
—
2.32
3.92
3.77
2.37
3.73
Cash per share
—
—
4.94
8.5
6.58
6.49
5.96
Net current asset value per share
—
—
6.04
11.1
10.12
11.84
11.94
Tangible book value per share
—
—
2.69
4.2
1.19
0.72
0.07
Working capital per share
—
—
3.67
8.04
5.32
4.22
3.36
Book value per share
—
—
2.69
4.2
1.19
1.77
1.07
News
Axsome's Auvelity: A New Treatment For Agitation In Alzheimer's Disease (AXSM)
Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders
Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review
AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales
Carillon Chartwell Small Cap Growth Fund: Q1 2026 Portfolio Movers
Axsome Therapeutics, Inc. (AXSM) Q1 2026 Earnings Call Transcript
Axsome Therapeutics Q1 2026 Earnings Review: Gains Mystify Me, But Can't Be Denied (AXSM)
Here's What Key Metrics Tell Us About Axsome (AXSM) Q1 Earnings
Axsome Continues Its Breakneck Pace On Solid First-Quarter Sales
Axsome Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:AXSM) 2026-05-04
Axsome Therapeutics (AXSM) Reports Q1 Loss, Beats Revenue Estimates
Market Week Ahead: Is May A Good Month For The Stock Market?